BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19443424)

  • 1. Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression.
    Tafuro S; Ayuso E; Zacchigna S; Zentilin L; Moimas S; Dore F; Giacca M
    Cardiovasc Res; 2009 Sep; 83(4):663-71. PubMed ID: 19443424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs.
    Chen F; Tan Z; Dong CY; Chen X; Guo SF
    Acta Pharmacol Sin; 2007 Apr; 28(4):493-502. PubMed ID: 17376288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
    Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P
    J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors.
    Zacchigna S; Papa G; Antonini A; Novati F; Moimas S; Carrer A; Arsic N; Zentilin L; Visintini V; Pascone M; Giacca M
    Am J Pathol; 2005 Oct; 167(4):981-91. PubMed ID: 16192634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo.
    Arsic N; Zacchigna S; Zentilin L; Ramirez-Correa G; Pattarini L; Salvi A; Sinagra G; Giacca M
    Mol Ther; 2004 Nov; 10(5):844-54. PubMed ID: 15509502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF therapy: a timely retreat.
    Alfranca A
    Cardiovasc Res; 2009 Sep; 83(4):611-2. PubMed ID: 19578068
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat.
    Milkiewicz M; Hudlicka O; Shiner R; Egginton S; Brown MD
    J Physiol; 2006 Dec; 577(Pt 2):671-8. PubMed ID: 16990404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization.
    Chen F; Tan Z; Dong CY; Li X; Xie Y; Wu Y; Chen X; Guo S
    Eur J Pharmacol; 2007 Jul; 568(1-3):222-30. PubMed ID: 17553485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle.
    Tang K; Breen EC; Gerber HP; Ferrara NM; Wagner PD
    Physiol Genomics; 2004 Jun; 18(1):63-9. PubMed ID: 15084712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle.
    Karvinen H; Pasanen E; Rissanen TT; Korpisalo P; Vähäkangas E; Jazwa A; Giacca M; Ylä-Herttuala S
    Gene Ther; 2011 Dec; 18(12):1166-72. PubMed ID: 21562595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer.
    Pajusola K; Künnapuu J; Vuorikoski S; Soronen J; André H; Pereira T; Korpisalo P; Ylä-Herttuala S; Poellinger L; Alitalo K
    FASEB J; 2005 Aug; 19(10):1365-7. PubMed ID: 15958522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
    Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH
    Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival of rat ischemic cutaneous and musculocutaneous flaps after VEGF gene transfer.
    Antonini A; Zacchigna S; Papa G; Novati F; Pascone M; Giacca M
    Microsurgery; 2007; 27(5):439-45. PubMed ID: 17596844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor--an alternative gene therapy.
    Celec P; Gardlík R; Pálffy R; Hodosy J; Stuchlík S; Drahovská H; Stuchlíková M; Minárik G; Lukács J; Jurkovicová I; Hulín I; Turna J; Jakubovský J; Kopáni M; Danisovic L; Jandzík D; Kúdela M; Yonemitsu Y
    Med Hypotheses; 2005; 64(3):505-11. PubMed ID: 15617857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.